Literature DB >> 1654265

Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.

P J Silver1, E D Pagani, L de Garavilla, G S Van Aller, M L Volberg, P F Pratt, R A Buchholz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1654265     DOI： 10.1016/0014-2999(91)90652-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  3 in total

1.  Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP.

Authors:  T Csont; Z Szilvássy; F Fülöp; S Nedeianu; T Páli; A Tosaki; L Dux; P Ferdinandy
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin.

Authors:  P Ferdinandy; Z Szilvássy; T Csont; C Csonka; E Nagy; M Koltai; L Dux
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 3.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.